JPS5191337A - - Google Patents

Info

Publication number
JPS5191337A
JPS5191337A JP51000124A JP12476A JPS5191337A JP S5191337 A JPS5191337 A JP S5191337A JP 51000124 A JP51000124 A JP 51000124A JP 12476 A JP12476 A JP 12476A JP S5191337 A JPS5191337 A JP S5191337A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51000124A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5191337A publication Critical patent/JPS5191337A/ja
Priority to US05/743,213 priority Critical patent/US4074654A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP51000124A 1975-01-06 1976-01-06 Pending JPS5191337A (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/743,213 US4074654A (en) 1976-01-06 1976-11-18 Automatic closure cleansing and coating machine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (1)

Publication Number Publication Date
JPS5191337A true JPS5191337A (no) 1976-08-10

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51000124A Pending JPS5191337A (no) 1975-01-06 1976-01-06

Country Status (14)

Country Link
JP (1) JPS5191337A (no)
AU (1) AU499140B2 (no)
BE (1) BE837293A (no)
CA (1) CA1063516A (no)
DE (1) DE2600069A1 (no)
FR (1) FR2296430A1 (no)
GB (1) GB1510370A (no)
HK (1) HK49680A (no)
IE (1) IE42766B1 (no)
IL (1) IL48785A (no)
MY (1) MY8100159A (no)
NL (1) NL7600045A (no)
NZ (1) NZ179623A (no)
ZA (2) ZA7628B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (no) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Also Published As

Publication number Publication date
ZA7626B (en) 1976-12-29
GB1510370A (en) 1978-05-10
CA1063516A (en) 1979-10-02
AU1000276A (en) 1977-07-14
IE42766L (en) 1976-07-06
IL48785A (en) 1978-08-31
BE837293A (fr) 1976-07-05
NZ179623A (en) 1978-03-06
FR2296430A1 (fr) 1976-07-30
MY8100159A (en) 1981-12-31
AU499140B2 (en) 1979-04-05
ZA7628B (en) 1976-12-29
HK49680A (en) 1980-09-12
DE2600069A1 (de) 1976-07-15
IE42766B1 (en) 1980-10-08
IL48785A0 (en) 1976-03-31
FR2296430B1 (no) 1978-11-10
NL7600045A (nl) 1976-07-08

Similar Documents

Publication Publication Date Title
JPS562660Y2 (no)
JPS578201B2 (no)
CH596460A5 (no)
CH602464A5 (no)
BG22644A1 (no)
BG22902A1 (no)
BG22950A1 (no)
BG26465A1 (no)
CH585100A5 (no)
CH586768A5 (no)
CH588681A5 (no)
CH589383A5 (no)
CH589455A5 (no)
CH590459A5 (no)
CH591641A5 (no)
CH591700A5 (no)
CH596588A5 (no)
CH592898A5 (no)
CH593320A5 (no)
CH594132A5 (no)
CH594218A5 (no)
CH594941A5 (no)
CH595435A5 (no)
BG22558A1 (no)
CH591803A5 (no)